Andrzej Jakubowiak to Immunoglobulin Light Chains
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Immunoglobulin Light Chains.
Connection Strength
0.525
-
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial. Leuk Lymphoma. 2011 Jul; 52(7):1271-80.
Score: 0.395
-
Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma. Leuk Lymphoma. 2015; 56(10):2959-61.
Score: 0.129